SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-141217
Filing Date
2024-05-17
Accepted
2024-05-17 08:01:00
Documents
13
Period of Report
2024-05-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d816348d8k.htm   iXBRL 8-K 43451
  Complete submission text file 0001193125-24-141217.txt   170102

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rgen-20240516.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20240516_lab.xml EX-101.LAB 18758
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20240516_pre.xml EX-101.PRE 11721
17 EXTRACTED XBRL INSTANCE DOCUMENT d816348d8k_htm.xml XML 3793
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 24957741
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)